NCT04047043View on ClinicalTrials.gov

Evaluation of Serum Taurine as a Prognostic Marker for Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

May 30, 2020

Study Completion Date

May 30, 2020

Conditions
Taurine
Interventions
DIAGNOSTIC_TEST

serum taurine

blood sample for serum taurine level

Trial Locations (1)

Unknown

Hanaa El Gendy, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04047043 - Evaluation of Serum Taurine as a Prognostic Marker for Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant | Biotech Hunter | Biotech Hunter